Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
Ranitidine hydrochloride
Ranbaxy Australia Pty Ltd
Medicine Registered
ULCAID CMI V3 Aug 2012 1 ULCAID _Ranitidine hydrochloride Tablets _ _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ULCAID. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking ULCAID against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THIS MEDICINE. You may need to read it again. WHAT ULCAID IS USED FOR The name of your medicine is ULCAID. It contains the active ingredient ranitidine hydrochloride. ULCAID belongs to a group of medicines called H 2 -antagonists or H 2 -blockers. ULCAID works by reducing the amount of acid produced by your stomach. ULCAID is used for the following: • to treat and prevent peptic ulcers. Peptic ulcers are ulcers that occur in the stomach or duodenum. • treatment of reflux or heartburn • Zollinger-Ellison Syndrome • Scleroderma oesophagitis By reducing the amount of acid produced by the stomach, ULCAID reduces the pain associated with the above conditions, helps ulcers to heal and helps heal oesphagitis. Your doctor may have prescribed ULCAID for another reason. Ask your doctor if you have any questions about why ULCAID has been prescribed for you. ULCAID is available only with a doctor’s prescription. ULCAID is not addictive. BEFORE YOU TAKE ULCAID _ _ _WHEN YOU MUST NOT TAKE IT_ ULCAID CMI V3 Aug 2012 2 DO NOT TAKE ULCAID IF YOU HAVE AN ALLERGY TO RANITIDINE OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLE Soma hati kamili
Ulcaid PI V3 Aug 12 1 PRODUCT INFORMATION ULCAID (150 MG AND 300 MG TABLETS) NAME OF THE MEDICINE Ulcaid tablets contain ranitidine hydrochloride. Its chemical structure is represented below: Chemical name: N-(2-(((5-[(dimethylamino)methyl]-2-furanyl)methyl)thio)ethyl)-N'-methyl-2- nitro-1,1-ethenediamine hydrochloride. CAS No.: 66357-59-3 Empirical Formula: C 13 H 22 N 4 O 3 S.HCl. MW: 350.9 DESCRIPTION Ranitidine hydrochloride is an aminoalkyl substituted furan and is structurally different from cimetidine, lacking the imidazole ring and the cyanoguanidine group. Each tablet of Ulcaid contains ranitidine hydrochloride equivalent to 150 mg or 300 mg of ranitidine. Each tablet also contains the following excipients: cellulose - microcrystalline, croscarmellose sodium, silica – colloidal anhydrous, purified talc, magnesium stearate, hypromellose, castor oil, iron oxide yellow, titanium dioxide, opacode-S-1-8152 HV Black. PHARMACOLOGY Ulcaid is a histamine H 2 -receptor antagonist. Animal experiments both _in vitro_ and _in vivo_ have established that ranitidine is a selective, competitive antagonist of histamine at H 2 -receptor sites. Ranitidine has no significant interaction at histamine H 1 -receptors, muscarinic receptors or beta-adrenoreceptors. Ranitidine is a potent inhibitor of gastric secretion in the rat and dog. All the evidence from human studies is compatible with a selective, competitive antagonism of histamine H 2 -receptors by ranitidine in humans. Oral or intravenous administration of ranitidine inhibits both basal gastric secretions and gastric acid secretion induced by histamine, pentagastrin and other secretagogues. On a weight basis ranitidine is between four and nine times more potent than cimetidine. Ulcaid PI V3 Aug 12 2 Soma hati kamili